RGS7BP
Regulator of G-protein signaling 7-binding protein
Also known as: R7BP, R7BP_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q6MZT1
- Gene
- RGS7BP
- Ensembl
- ENSG00000186479
- Chromosome
- 5
- Canonical length
- 257 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Plasma membrane,Actin filaments,Cytosol
OverviewNCBI Gene
This gene encodes a protein that binds to all members of the R7 subfamily of regulators of G protein signaling and regulates their translocation between the nucleus and the plasma membrane. The encoded protein could be regulated by reversible palmitoylation, which anchors it to the plasma membrane. Depalmitoylation localizes the protein to the nucleus. Polymorphisms in this gene may be associated with risk of aspirin-exacerbated respiratory disease. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Dec 2012]
Canonical amino-acid sequenceUniProt
257 residues, UniProt reviewed canonical sequence.
>Q6MZT1|RGS7BP
1 MSSAPNGRKK RPSRSTRSSI FQISKPPLQS GDWERRGSGS ESAHKTQRAL DDCKMLVQEF
61 NTQVALYREL VISIGDVSVS CPSLRAEMHK TRTKGCEMAR QAHQKLAAIS GPEDGEIHPE
121 ICRLYIQLQC CLEMYTTEML KSICLLGSLQ FHRKGKEPGG GTKSLDCKIE ESAETPALED
181 SSSSPVDSQQ HSWQVSTDIE NTERDMREMK NLLSKLRETM PLPLKNQDDS SLLNLTPYPL
241 VRRRKRRFFG LCCLISSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against RGS7BP can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.47
- Highest tissue expression
- 22 nTPM
Expression across tissuesHPA
Tissue
- cerebral cortex: 22 nTPM
- fallopian tube: 7.4 nTPM
- seminal vesicle: 7 nTPM
- basal ganglia: 5 nTPM
- prostate: 5 nTPM
- cerebellum: 4.9 nTPM
Single-cell type
- brain inhibitory neurons: 181 nCPM
- thyrotrophs: 136 nCPM
- retinal amacrine cells: 135 nCPM
- retinal ganglion cells: 128 nCPM
- brain excitatory neurons: 125 nCPM
- adrenal medulla cells: 85 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- cerebral cortex: 106 nTPM
- basal ganglia: 70 nTPM
- thalamus: 60 nTPM
- white matter: 59 nTPM
- hippocampal formation: 54 nTPM
- cerebellum: 40 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.33
- gnomAD pLI
- 0.96
- gnomAD missense Z
- 1.02
- DepMap mean gene effect
- -0.01
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- G protein-coupled receptor signaling pathway
- negative regulation of signal transduction
- regulation of postsynaptic membrane potential
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of RGS7BP in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads RGS7BP as an antibody target. Whether an autoantibody or antibody against RGS7BP could matter depends on whether native RGS7BP is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
RGS7BP is annotated at the cell surface, where native RGS7BP is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label RGS7BP as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...